J Rainer Twiford
CIK 1405588 · last filed 2023-04-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
34
Lifetime Open-Market Net
-$163.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Tracon Pharmaceuticals, Inc. (TCON) Delisted | Director | — | $0.03 | — | $0 | 4 | 2023-04-21 |
| CRE | Director | 0 | $2.94 | $0 | -$163.5K | 12 | 2010-08-13 |
Recent Filings · Page 3 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-01-04 | — | Grant (A) | +789 | $3.7K | |
| 2010-10-20 | — | Grant (A) | +399 | $2.0K | |
| 2010-08-13 | CRE | U | −2,844 | -$25.6K | EDGAR |
| 2010-07-02 | CRE | Grant (A) | +1,443 | $12.5K | EDGAR |
| 2010-04-12 | CRE | Grant (A) | +1,401 | $12.5K | EDGAR |
| 2010-03-22 | CRE | Sell (S) | −18,334 | -$163.5K | EDGAR |
| 2010-01-05 | CRE | Grant (A) | +1,606 | $12.5K | EDGAR |
| 2009-10-05 | CRE | Grant (A) | +1,629 | $12.2K | EDGAR |
| 2009-07-06 | CRE | Grant (A) | +2,403 | $12.5K | EDGAR |
| 2009-04-03 | CRE | Grant (A) | +2,289 | $12.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.